RB

Raju Bittanakurike Ramakrishnaiah

Active Director Director DIN 11073455
DIN 11073455 First appointment Apr 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Raju Bittanakurike Ramakrishnaiah

Data last updated:

Raju Bittanakurike Ramakrishnaiah is a Director at Scb Biotech Private Limited (since 2025). The company operates in Healthcare.

DIN 11073455
Primary Designation Director
Industry Healthcare
First Appointment 24 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Scb Biotech Private Limited U46497KA2025PTC201892
Director24 Apr 20252025Active

Board colleagues of Raju Bittanakurike Ramakrishnaiah

NameDINCompanyDesignation
Channappa Hatti11073456Scb Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Scb Biotech Private Limited
Premium access

Shareholding and investment profile for Raju Bittanakurike Ramakrishnaiah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raju Bittanakurike Ramakrishnaiah

Raju Bittanakurike Ramakrishnaiah currently holds 1 directorship: Scb Biotech Private Limited (Director, since 24 Apr 2025).

Raju Bittanakurike Ramakrishnaiah was first appointed on 24 Apr 2025 as Director at Scb Biotech Private Limited.

The current boards of Raju Bittanakurike Ramakrishnaiah's companies include Channappa Hatti (Scb Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available